This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Feb 8;395(10222):415.

doi: 10.1016/S0140-6736(19)32491-2.

Perception of severity of adverse events in oral immunotherapy

Michael R Perkin¹

Affiliations

PMID: 32035549
DOI: 10.1016/S0140-6736(19)32491-2

Comment

Perception of severity of adverse events in oral immunotherapy

Michael R Perkin. Lancet. 2020.

. 2020 Feb 8;395(10222):415.

doi: 10.1016/S0140-6736(19)32491-2.

Author

Michael R Perkin¹

Affiliation

¹ Population Health Research Institute, St George's University of London, London SW17 0RE, UK. Electronic address: mperkin@sgul.ac.uk.

PMID: 32035549
DOI: 10.1016/S0140-6736(19)32491-2

No abstract available

PubMed Disclaimer

Comment in

Perception of severity of adverse events in oral immunotherapy - Authors' reply.
Chu DK, Wood RA, French S, Fiocchi A, Waserman S, Schünemann HJ; PACE study group. Chu DK, et al. Lancet. 2020 Feb 8;395(10222):415-416. doi: 10.1016/S0140-6736(19)32567-X. Lancet. 2020. PMID: 32035550 No abstract available.

Comment on

Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety.
Chu DK, Wood RA, French S, Fiocchi A, Jordana M, Waserman S, Brożek JL, Schünemann HJ. Chu DK, et al. Lancet. 2019 Jun 1;393(10187):2222-2232. doi: 10.1016/S0140-6736(19)30420-9. Epub 2019 Apr 25. Lancet. 2019. PMID: 31030987

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science